Diverse gene expression patterns in response to anticancer drugs between human and mouse cell lines revealed by a...

Area of Science:

• Genomics
• Pharmacology
• Cancer Research

Background:

• Anticancer drug efficacy can vary between species.
• Understanding conserved and divergent antitumor mechanisms is crucial for drug development.

Purpose of the Study:

• To conduct comparative genomics of gene expression in mice and humans treated with anticancer drugs.
• To identify similarities and differences in antitumor mechanisms.
• To provide a theoretical basis for drug design.

Main Methods:

• Data mining of antitumor gene expression regulation.
• Screening of genetic loci from experimental mouse models.
• Analysis of gene expression profile datasets from mouse and human cell lines treated with PD0332991 (a cyclin-dependent kinase 4/6 inhibitor).

Main Results:

• Identified 9 overlapping genes with opposing expression patterns in mouse and human cell lines treated with PD0332991.
• Key genes identified include LIM homeobox 2, adenomedullin, and histone cluster 1 (HIST1) family members.
• Identified candidate pathways: janus kinase-signal transducer and activator of transcription, Toll-like receptor, T cell receptor, and nucleotide-binding oligomerization domain-like receptor signaling pathways.

Conclusions:

• Comparative genomics can elucidate conserved and divergent antitumor mechanisms.
• The identified genes and pathways provide a foundation for targeted drug design.
• Understanding species-specific responses is vital for effective anticancer therapies.